Ameriprise’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Ameriprise's OGN Position: Q1 2026 in Review
Ameriprise increased its Organon & Co (OGN) stake by 20% in Q1 2026, buying an estimated $929K and bringing the position to 754,240 shares worth $4.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2501.
Ameriprise first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $23.9M in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Ameriprise held 754,240 shares of Organon & Co worth $4.52M as of Q1 2026.
- Ameriprise bought 123,442 Organon & Co shares in Q1 2026, an estimated $929K.
- Organon & Co made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2501 holding.
- Ameriprise first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- Ameriprise's Organon & Co position peaked at $23.9M in Q1 2022.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.